Inhibition on Proteasome β1 Subunit Might Contribute to the Anti-Cancer Effects of Fangchinoline in Human Prostate Cancer Cells

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Oct 30

PMID 26512898

Citations 13

Authors

Dong Li

Yu Lu

Peng Sun

Li-Xing Feng

Miao Liu

Li-Hong Hu

Wan-Ying Wu

Bao-Hong Jiang

Min Yang

Xiao-Bo Qu

De-An Guo

Xuan Liu

Affiliations

Soon will be listed here.

Abstract

Fangchinoline is a bisbenzylisoquinoline alkaloid isolated from Radix Stephaniae tetrandrae S. Moore. Fangchinoline and its structure analogue, tetrandrine, exhibited direct binding affinity with recombinant human proteasome β1 subunit and also inhibited its activity in vitro. In cultured prostate PC-3 cells and LnCap cells, fangchinoline could dose-dependently inhibit cell proliferation and caspase-like activity of cellular proteasome which was mediated by proteasome β1 subunit. The inhibitive effect of fangchinoline on caspase-like activity of proteasome was also observed in purified human erythrocyte 20S proteasome. In PC-3 cells, fangchinoline induced cell cycle arrest at G0/G1 phase and apoptosis. Treatment of PC-3 tumor-bearing nude mice with fangchinoline inhibited tumor growth, induced apoptosis and also caused decrease in proteasome activities in tumor xenografts. Dose-dependent and time-dependent accumulation of ubiquitinated proteins and important proteasome substrates such as p27, Bax and IκB-α were observed in fangchinoline-treated cells. Over-expression of proteasome β1 subunit by plasmid transfection increased sensitivity of cells to the cytotoxicity of fangchinoline while knockdown of proteasome β1 subunit ameliorated cytotoxicity of fangchinoline in PC-3 cells. Results of the present study suggested that proteasome inhibition was involved in the anti-cancer effects of fangchinoline. Fangchinoline and its structure analogues might be new natural proteasome inhibitors targeting β1 subunit.

Citing Articles

Derived from fangchinoline, LYY-35 exhibits an inhibiting effect on human NSCLC cancer A549 cells.

Wang B, Long S, Lan J, Luo K, Zhang W, Li X J Cancer. 2024; 15(13):4232-4243.

PMID: 38947387 PMC: 11212078. DOI: 10.7150/jca.96582.

Fangchinoline alleviates cognitive impairments through enhancing autophagy and mitigating oxidative stress in Alzheimer's disease models.

Yi L, Luo M, Wang M, Dong Z, Du Y Front Cell Dev Biol. 2023; 11:1288506.

PMID: 38146492 PMC: 10749363. DOI: 10.3389/fcell.2023.1288506.

Potential Focal Adhesion Kinase Inhibitors in Management of Cancer: Therapeutic Opportunities from Herbal Medicine.

Chen F, Zhong Z, Zhang C, Lu Y, Chan Y, Wang N Int J Mol Sci. 2022; 23(21).

PMID: 36362132 PMC: 9659249. DOI: 10.3390/ijms232113334.

Plant Alkaloid Tetrandrine Is a Nuclear Receptor 4A1 Antagonist and Inhibits Panc-1 Cell Growth In Vitro and In Vivo.

Lee H, Kim D, Lee I, Park J, Martin G, Safe S Int J Mol Sci. 2022; 23(9).

PMID: 35563670 PMC: 9104798. DOI: 10.3390/ijms23095280.

Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis.

Li J, Cen W, Tong C, Wang L, Zhang W, Deng S PLoS One. 2022; 17(4):e0266738.

PMID: 35446864 PMC: 9022853. DOI: 10.1371/journal.pone.0266738.

References

Yuan F, Ma Y, You P, Lin W, Lu H, Yu Y . A novel role of proteasomal β1 subunit in tumorigenesis. Biosci Rep. 2013; 33(4). PMC: 3712487. DOI: 10.1042/BSR20130013. View

Li B, Dou Q . Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. Proc Natl Acad Sci U S A. 2000; 97(8):3850-5. PMC: 18105. DOI: 10.1073/pnas.070047997. View

Yue Q, Xie F, Guan S, Ma C, Yang M, Jiang B . Interaction of Ganoderma triterpenes with doxorubicin and proteomic characterization of the possible molecular targets of Ganoderma triterpenes. Cancer Sci. 2008; 99(7):1461-70. PMC: 11159042. DOI: 10.1111/j.1349-7006.2008.00824.x. View

Wang C, Huang J, Gao X, Li Y, Zhou S, Yan X . Fangchinoline induced G1/S arrest by modulating expression of p27, PCNA, and cyclin D in human prostate carcinoma cancer PC3 cells and tumor xenograft. Biosci Biotechnol Biochem. 2010; 74(3):488-93. DOI: 10.1271/bbb.90490. View

Sun Y, Wink M . Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells. Phytomedicine. 2014; 21(8-9):1110-9. DOI: 10.1016/j.phymed.2014.04.029. View

Wu J, Chen Y, Chen J, Lin T, Tseng S . Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice. Cancer Lett. 2009; 287(2):187-95. DOI: 10.1016/j.canlet.2009.06.009. View

Liu W, Kou B, Ma Z, Tang X, Lv C, Ye M . Tetrandrine suppresses proliferation, induces apoptosis, and inhibits migration and invasion in human prostate cancer cells. Asian J Androl. 2015; 17(5):850-3. PMC: 4577603. DOI: 10.4103/1008-682X.142134. View

Huang A, Lien J, Lin M, Yang J, Wu P, Chang S . Tetrandrine induces cell death in SAS human oral cancer cells through caspase activation-dependent apoptosis and LC3-I and LC3-II activation-dependent autophagy. Int J Oncol. 2013; 43(2):485-94. DOI: 10.3892/ijo.2013.1952. View

Chen X, Ren K, He H, Shao R . Involvement of PI3K/AKT/GSK3beta pathway in tetrandrine-induced G1 arrest and apoptosis. Cancer Biol Ther. 2008; 7(7):1073-8. DOI: 10.4161/cbt.7.7.6142. View

10.

Yerlikaya A, Yontem M . The significance of ubiquitin proteasome pathway in cancer development. Recent Pat Anticancer Drug Discov. 2012; 8(3):298-309. DOI: 10.2174/1574891x113089990033. View

11.

Lee J, Kang G, Kim K, Kim K, Park D, Choi B . Tetrandrine-induced cell cycle arrest and apoptosis in A549 human lung carcinoma cells. Int J Oncol. 2002; 21(6):1239-44. View

12.

Wu S, Yu X, Shan J, Wong T, Chen C, Pang K . Cardiac effects of the extract and active components of Radix stephaniae tetrandrae. I. Electrically-induced intracellular calcium transient and protein release during the calcium paradox. Life Sci. 2001; 68(25):2853-61. DOI: 10.1016/s0024-3205(01)01068-2. View

13.

Bedford L, Lowe J, Dick L, Mayer R, Brownell J . Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov. 2010; 10(1):29-46. PMC: 7097807. DOI: 10.1038/nrd3321. View

14.

Weathington N, Mallampalli R . Emerging therapies targeting the ubiquitin proteasome system in cancer. J Clin Invest. 2014; 124(1):6-12. PMC: 3871250. DOI: 10.1172/JCI71602. View

15.

Kuo P, Lin C . Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells. Life Sci. 2003; 73(2):243-52. DOI: 10.1016/s0024-3205(03)00266-2. View

16.

Tambyrajah W, Bowler L, Medina-Palazon C, Sinclair A . Cell cycle-dependent caspase-like activity that cleaves p27(KIP1) is the beta(1) subunit of the 20S proteasome. Arch Biochem Biophys. 2007; 466(2):186-93. DOI: 10.1016/j.abb.2007.07.019. View

17.

Corbett E, Bailey R, Mabey D, Raynes J, Conway D . Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis. Genes Immun. 2001; 2(3):153-5. DOI: 10.1038/sj.gene.6363753. View

18.

Wojcik S . Crosstalk between autophagy and proteasome protein degradation systems: possible implications for cancer therapy. Folia Histochem Cytobiol. 2014; 51(4):249-64. DOI: 10.5603/FHC.2013.0036. View

19.

Wang N, Pan W, Zhu M, Zhang M, Hao X, Liang G . Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells. Br J Pharmacol. 2011; 164(2b):731-42. PMC: 3188903. DOI: 10.1111/j.1476-5381.2011.01349.x. View

20.

Senthil Murugan R, Vidya Priyadarsini R, Ramalingam K, Hara Y, Karunagaran D, Nagini S . Intrinsic apoptosis and NF-κB signaling are potential molecular targets for chemoprevention by black tea polyphenols in HepG2 cells in vitro and in a rat hepatocarcinogenesis model in vivo. Food Chem Toxicol. 2010; 48(11):3281-7. DOI: 10.1016/j.fct.2010.09.002. View